109 related articles for article (PubMed ID: 22825467)
21. JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemia.
Zhang Z; Shi J; Wu Q; Zhang Z; Liu X; Ren A; Zhao G; Dong G; Wu H; Zhao J; Zhao Y; Hu J; Li H; Zhang T; Zhou F; Zhu H
iScience; 2023 Nov; 26(11):108242. PubMed ID: 38026210
[TBL] [Abstract][Full Text] [Related]
22. LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance.
Michalek S; Goj T; Plazzo AP; Marovca B; Bornhauser B; Brunner T
EMBO Rep; 2022 Sep; 23(9):e54195. PubMed ID: 35801407
[TBL] [Abstract][Full Text] [Related]
23. The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms.
Zhu B; Qu S
Front Endocrinol (Lausanne); 2022; 13():800995. PubMed ID: 35222270
[TBL] [Abstract][Full Text] [Related]
24. The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway through suppressing ARHGAP18.
Liang L; Gu W; Li M; Gao R; Zhang X; Guo C; Mi S
Cell Death Dis; 2021 Jul; 12(7):702. PubMed ID: 34262023
[TBL] [Abstract][Full Text] [Related]
25.
Sharvit L; Bar-Shalom R; Azzam N; Yechiel Y; Wasser S; Fares F
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922003
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone.
Luchak A; Solomon LA; Kanagalingam T; Vijeyakumaran M; Rowe BH; Cameron L
BMC Immunol; 2020 Oct; 21(1):54. PubMed ID: 33076829
[TBL] [Abstract][Full Text] [Related]
27. Prolonged unfolded protein reaction is involved in the induction of chronic myeloid leukemia cell death upon oprozomib treatment.
Wang F; Wang X; Li N; Liu J; Zhang L; Hui L; Feng A; Wang Z; Wang Y
Cancer Sci; 2021 Jan; 112(1):133-143. PubMed ID: 33067904
[TBL] [Abstract][Full Text] [Related]
28. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.
Autry RJ; Paugh SW; Carter R; Shi L; Liu J; Ferguson DC; Lau CE; Bonten EJ; Yang W; McCorkle JR; Beard JA; Panetta JC; Diedrich JD; Crews KR; Pei D; Coke CJ; Natarajan S; Khatamian A; Karol SE; Lopez-Lopez E; Diouf B; Smith C; Gocho Y; Hagiwara K; Roberts KG; Pounds S; Kornblau SM; Stock W; Paietta EM; Litzow MR; Inaba H; Mullighan CG; Jeha S; Pui CH; Cheng C; Savic D; Yu J; Gawad C; Relling MV; Yang JJ; Evans WE
Nat Cancer; 2020 Mar; 1(3):329-344. PubMed ID: 32885175
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia.
Gebru MT; Atkinson JM; Young MM; Zhang L; Tang Z; Liu Z; Lu P; Dower CM; Chen L; Annageldiyev C; Sharma A; Imamura Kawasawa Y; Zhao Z; Miller BA; Claxton DF; Wang HG
Blood; 2020 Aug; 136(9):1067-1079. PubMed ID: 32396937
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PERK Signaling Prevents Against Glucocorticoid-induced Endotheliocyte Apoptosis and Osteonecrosis of the Femoral Head.
Gao Y; Zhu H; Wang Q; Feng Y; Zhang C
Int J Biol Sci; 2020; 16(4):543-552. PubMed ID: 32025204
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.
Strehl C; Ehlers L; Gaber T; Buttgereit F
Front Immunol; 2019; 10():1744. PubMed ID: 31396235
[TBL] [Abstract][Full Text] [Related]
32. IL-2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?
Kanagalingam T; Solomon L; Vijeyakumaran M; Palikhe NS; Vliagoftis H; Cameron L
Immun Inflamm Dis; 2019 Sep; 7(3):112-124. PubMed ID: 30994266
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of cytokine combinations against the apoptotic activity of glucocorticoids on CD34
Erdem Kuruca S; Çetin MB; Akgün Dar K; Özerkan D
Cytotechnology; 2019 Feb; 71(1):67-77. PubMed ID: 30603917
[TBL] [Abstract][Full Text] [Related]
34. RUNX2 Promotes Malignant Progression in Glioma.
Yamada D; Fujikawa K; Kawabe K; Furuta T; Nakada M; Takarada T
Neurochem Res; 2018 Nov; 43(11):2047-2054. PubMed ID: 30203400
[TBL] [Abstract][Full Text] [Related]
35. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].
Xu JY; Luo JM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):945-949. PubMed ID: 28774373
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial determinants of cancer health disparities.
Choudhury AR; Singh KK
Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
[TBL] [Abstract][Full Text] [Related]
38. Involvement of small G protein RhoB in the regulation of proliferation, adhesion and migration by dexamethasone in osteoblastic cells.
Diao F; Chen K; Wang Y; Li Y; Xu W; Lu J; Chen YX
PLoS One; 2017; 12(3):e0174273. PubMed ID: 28323887
[TBL] [Abstract][Full Text] [Related]
39. The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure.
Yeo S; Enoch MA; Gorodetsky E; Akhtar L; Schuebel K; Roy A; Goldman D
Genes Brain Behav; 2017 Feb; 16(2):223-232. PubMed ID: 27648526
[TBL] [Abstract][Full Text] [Related]
40. Co-Managing Patients with Type 1 Diabetes and Cancer.
Best CJ; Thosani S; Ortiz M; Levesque C; Varghese SS; Lavis VR
Curr Diab Rep; 2016 Aug; 16(8):73. PubMed ID: 27319323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
